{
    "id": 4619,
    "fullName": "PIK3CB over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CB over exp indicates an over expression of the Pik3cb protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 5291,
        "geneSymbol": "PIK3CB",
        "terms": [
            "PIK3CB",
            "P110BETA",
            "PI3K",
            "PI3KBETA",
            "PIK3C1"
        ]
    },
    "variant": "over exp",
    "createDate": "04/09/2015",
    "updateDate": "11/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8557,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Rigosertib (ON 01910.Na) inhibited oncogenic transformation in fibroblast cells over-expressing Pik3cb in culture (PMID: 27104980).",
            "molecularProfile": {
                "id": 4416,
                "profileName": "PIK3CB over exp"
            },
            "therapy": {
                "id": 1046,
                "therapyName": "Rigosertib Sodium",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6686,
                    "pubMedId": 27104980,
                    "title": "A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27104980"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5072,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, IC87114 inhibited proliferation and induced apoptosis in primary patient-derived acute promyelocytic leukemia cells with elevated Pik3cb and decreased Pik3ca protein expression in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20234,
                "profileName": "PIK3CA dec exp PIK3CB over exp"
            },
            "therapy": {
                "id": 3504,
                "therapyName": "IC87114",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5070,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, LY294002 inhibited proliferation of primary patient-derived acute promyelocytic leukemia cells with elevated Pik3cb and decreased Pik3ca protein expression in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20234,
                "profileName": "PIK3CA dec exp PIK3CB over exp"
            },
            "therapy": {
                "id": 1062,
                "therapyName": "LY294002",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5071,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, TGX-221 treatment inhibited proliferation and induced apoptosis in primary patient-derived acute promyelocytic leukemia cells with elevated Pik3cb and decreased Pik3ca protein expression in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20234,
                "profileName": "PIK3CA dec exp PIK3CB over exp"
            },
            "therapy": {
                "id": 2514,
                "therapyName": "TGX-221",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5069,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, PI-103 treatment inhibited proliferation and induced apoptosis in primary patient-derived acute promyelocytic leukemia cells with elevated Pik3cb and decreased Pik3ca protein expression in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20234,
                "profileName": "PIK3CA dec exp PIK3CB over exp"
            },
            "therapy": {
                "id": 870,
                "therapyName": "PI-103",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5073,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Rapamune (sirolimus) inhibited proliferation and induced apoptosis in primary patient-derived acute promyelocytic leukemia cells with elevated Pik3cb and decreased Pik3ca protein expression in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20234,
                "profileName": "PIK3CA dec exp PIK3CB over exp"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 4416,
            "profileName": "PIK3CB over exp",
            "profileTreatmentApproaches": [
                {
                    "id": 3337,
                    "name": "PIK3CB inhibitor",
                    "profileName": "PIK3CB over exp"
                },
                {
                    "id": 3336,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "PIK3CB over exp"
                }
            ]
        },
        {
            "id": 20234,
            "profileName": "PIK3CA dec exp PIK3CB over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}